Business | Zydus and Formycon’s Keytruda® biosimilar accepted for USFDA review
Read the Zydus Lifesciences Limited announcement filed with the NSE, with the key figures and what it means for shareholders. The post Zydus and Formycon’s Keytruda® biosimilar accepted for USFDA review appeared first on TaxGuru .
Attribution
Original credit: TG Team. This digest is published with acknowledgment to TaxGuru. For the complete analysis, headnotes, and citations, please refer to the source.
Read on TaxGuru